Intensive – Page 43 – Communicable Diseases Research

Psychiatric face of COVID-19

Review Article

Published on 2020-07-302022-10-04
Journal: Translational Psychiatry [Category] SARS, 바이오마커, 변종, 치료제,

Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies

Research Article

Published on 2020-07-302022-10-28
Journal: BMC Medicine [Category] Coronavirus, SARS,

[키워드] 95% confidence interval age average calibrated caused changes in condition Contact COVID-19 COVID-19 epidemic COVID-19 pandemic Critical Effectiveness evaluate evaluated Exit strategies expected Extensive extreme First wave form France Health healthcare Healthcare system Hospital admission ICU Impact Intensive Isolation Large-scale testing lifting lockdown management mathematical modeling Measures Model Non-pharmaceutical interventions physical contact population immunity reduction reproductive reproductive number required response Result second wave social contact social distancing the disease the epidemic Transmission model
[DOI] 10.1186/s12916-020-01698-4 PMC 바로가기 [Article Type] Research Article

Sequence analysis and pathogenicity of Avian Orthoavulavirus 1 strains isolated from poultry flocks during 2015–2019

Research Article

Published on 2020-07-222022-10-28
Journal: BMC veterinary research [Category] Coronavirus,

[키워드] Amino acid residue substitution Analysis Avian Orthoavulavirus 1 cause Co-infection decrease Delta disease examined F protein fusion protein gene sequence genetic analysis Genotype glycosylation high mortality highly pathogenic IBV indicated Infectious Bronchitis Virus Influenza Intensive Intracerebral isolate isolates Isolation molecular motif neutralizing epitopes newcastle disease virus pathogenic pathogenicity positive Prevalence primer qRT-PCR ranged RBCs reduce residue respiratory viral disease Result selected sequenced Sequencing Seven Spread strain submitted suffered tested vaccination Vaccines
[DOI] 10.1186/s12917-020-02470-9 PMC 바로가기 [Article Type] Research Article

A qualitative study of the vocational and psychological perceptions and issues of transdisciplinary nurses during the COVID-19 outbreak

Research Paper

Published on 2020-07-152022-10-28
Journal: Aging (Albany NY) [Category] COVID-19, SARS,

COVID-19: The Need for Rational Use of Face Masks in Nigeria

Perspective Piece

Published on 2020-07-152022-10-28
Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, MERS, SARS,

[키워드] applicability Community Consequences Contamination country COVID-19 pandemic Critical effort face Face mask feasibility Government healthcare identify implementation Intensive Local mandatory Mask media mitigate Nigeria Novel coronavirus pandemic of COVID-19 potential risk promote reported Spread wear face mask wear face masks
[DOI] 10.4269/ajtmh.20-0433 PMC 바로가기 [Article Type] Perspective Piece

Spontaneous Pneumomediastinum Associated With SARS-CoV-2: Infrequent Complication of the Novel Disease

Radiology

Published on 2020-07-142022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] acute respiratory distress Acute respiratory infection acute respiratory syndrome biochemical chest infection chronic lung diseases Comorbidity Complication complications coronavirus develop diagnosed Diagnosis distribution emphysema fatigue global pandemic ground-glass opacity had no Health highlight Hospitalization Infection Infrequent Intensive Laboratory results male management medical condition myalgia nausea noninvasive novel Novel coronavirus oxygen supply pandemic Patient pharmacological treatment Pneumomediastinum Pneumonia radiological SARS-CoV-2 SARS-CoV2 Shortness of breath significantly smoking Spontaneous subsequent Symptom syndrome the disease the patient Treatment
[DOI] 10.7759/cureus.9189 PMC 바로가기 [Article Type] Radiology

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-07-142022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] 48 hour addition Administered adverse effect allergy Alpha anticipated assumed baseline blinded to treatment block clinical Clinical outcome Comorbidity COVID-19 data management Day death determine dissemination drug interaction element eligible eligible participant enrolment evaluate evaluated excluded expected group hospital hospitalised hospitalised patient Hydroxychloroquine independent Intensive intensive care Intervention intervention arms invasive investigator investigator-initiated Laboratory Lopinavir management men New no interaction non-invasive ventilation nucleic acid number objective Open-label outcome participant Patient platform Primary outcome proportion Proportion of participant protocol provided QTC prolongation randomisation randomised randomised controlled trial receive receiving recruited reduce Registered registry representing required researcher Respiratory Support risk Ritonavir Sample size SARS-CoV-2 SARS-COV-2 infection secondary outcome sequence significance level Standard of care status stratified study drug Study protocol Tablet total sample size treated Trial two-sided unblinding ventilatory support Virological website women
[DOI] 10.1186/s13063-020-04576-9 PMC 바로가기 [Article Type] Letter

Social determinants of health: the role of effective communication in the COVID-19 pandemic in developing countries

Research Article

Published on 2020-07-132022-10-31
Journal: Global Health Action [Category] COVID-19, MERS, SARS,

Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan

Article

Published on 2020-07-072022-11-01
Journal: Journal of Clinical Virology [Category] COVID-19, MERS,

Estimation of country-level basic reproductive ratios for novel Coronavirus (SARS-CoV-2/COVID-19) using synthetic contact matrices

Research Article

Published on 2020-07-022022-10-28
Journal: PLoS Computational Biology [Category] COVID-19, SARS,

[키워드] 2019 novel coronavirus age America Asia assumed Asymptomatic Asymptomatic case Atypical calculate caused children China Clinical symptoms comparable complex Contact country COVID-19 COVID-19 transmission dependent on driven by epidemiological data estimate estimation Europe Frequency generate groups heterogeneity highest individual infect Infection intensity Intensive Japan laboratory-confirmed lowest mathematical measure Mild null model Older Older age outbreak over pandemic pathogen pathogen’ Pneumonia populations predict predicted Probability reported reproductive reversed SARS-CoV-2 Spread spread of COVID-19 Structure susceptibility Symptom the disease Transmission Transmission model virus
[DOI] 10.1371/journal.pcbi.1008031 PMC 바로가기 [Article Type] Research Article